Text size :

Rare diseases: 10 years of extended neonatal screening, Uniamo ‘the challenge is to update the panel’ (2)

ADNKRONOS

November 11, 2026

(Adnkronos Health) – The Italian model – the note continues – was also mentioned during the speech by Daniel de Vicente, advisor to Feder, the Spanish Federation for Rare Diseases, who spoke about the approval of the national law on neonatal screening in Spain last August. The Italian model, 10 years on, must now continue to evolve to embrace the opportunities offered by scientific and technological progress, starting from the new possibilities offered by genetic analysis techniques, which open up further prospects for early diagnosis but also require a system capable of equipping itself to manage their implications.

During the event, speakers included: bioethicist Silvia Ceruti from the University of Insubria; Maria Iascone from Sigu – Italian Society of Human Genetics; Margherita Ruoppolo from Simmens – Italian Society for the Study of Hereditary Metabolic Diseases and Neonatal Screening; Manuela Vaccarotto from Aismme – Italian Association for Support of Hereditary Metabolic Diseases. The discussion highlighted the need to accompany innovation with careful reflection on appropriateness, ethical implications, and how new knowledge can translate into concrete opportunities for children and their families. Andrea Piccioli, Director General of the ISS, spoke about the role of the National Coordination Centre for Sne, emphasizing the importance of a coordinating function to accompany the program’s evolution and support a homogeneous and effective system throughout the national territory.

“10 years after the approval of Law 167/2016, the priority is to consolidate an equitable, homogeneous neonatal screening system capable of promptly incorporating scientific innovations – Scattoni emphasized – It is fundamental to make the National Archive of Extended Neonatal Screening fully operational, an indispensable institutional tool for monitoring the program’s effectiveness, identifying any territorial disparities, and guiding health policies based on reliable and shared data.” The morning concluded with a round table dedicated to the political challenge, which involved Simona Bellagambi, Eurordis councilor and Uniamo’s foreign delegate; the Honorable Maria Elena Boschi, president of the Parliamentary Intergroup for Rare and Oncohematological Diseases; the Honorable Ilenia Malavasi and Maria Grazia Privitera, medical health director of the General Directorate for Prevention at the Ministry of Health. At the center of the discussion were the necessary conditions to ensure equitable access to screening, the scheduling of panel updates, and the sustainability of the system, issues that call into question the responsibility of institutions and politics in providing continuity to a program that represents a fundamental tool for prevention and public health. The outcome is an important achievement, but also a commitment that cannot be considered concluded: for scientific progress to become real opportunities for all newborns and their families, the system must be able to recognize and incorporate them promptly, maintaining equity as an essential reference.

Jiji Press

Related

Page TOP